Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | +5.26% | +5.26% | +15.38% |
2022 | PharmChem, Inc.'s Equity Buyback announced on May 2, 2022, has cancelled. | CI |
2022 | PharmChem, Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
Sales 2001 | 43.98M 3.67B | Sales 2002 | 30.08M 2.51B | Capitalization | 1.35M 112M |
---|---|---|---|---|---|
Net income 2001 | -8M -668M | Net income 2002 | 3M 251M | EV / Sales 2001 | 0.37 x |
Net Debt 2001 | 10.89M 910M | Net Debt 2002 | 2.32M 194M | EV / Sales 2002 | 0.12 x |
P/E ratio 2001 |
-0.66
x | P/E ratio 2002 |
0.4
x | Employees | - |
Yield 2001 * |
-
| Yield 2002 |
-
| Free-Float | 96.52% |
1 day | +5.26% | ||
1 week | +5.26% | ||
1 month | +9.09% | ||
3 months | +16.73% | ||
6 months | +13.21% | ||
Current year | +15.38% |
Managers | Title | Age | Since |
---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Shana Veale
DFI | Director of Finance/CFO | - | 01/17/01 |
Douglas Crook
COO | Chief Operating Officer | - | 01/97/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Tim Eriksen
CHM | Chairman | 55 | 31/21/31 |
James Ford
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+15.38% | 13.94M | |
-25.06% | 7.76B | |
+68.54% | 4.35B | |
+2.59% | 2.67B | |
-2.45% | 2.64B | |
-47.56% | 2.1B | |
-17.52% | 1.73B | |
-20.23% | 1.52B | |
+12.59% | 1.18B | |
-45.36% | 1.11B |
- Stock Market
- Equities
- PCHM Stock